EX-99.2 4 ex_620924.htm EXHIBIT 99.2 ex_620924.htm

Exhibit 99.2

 

Unaudited Pro Forma Condensed Consolidated Financial Statements

 

 

On January 24, 2024, RiceBran Technologies (“the Company”) completed the sale of certain assets exclusively related to the Company’s production of No. 1 and No. 2 Grade U.S. premium long and medium white rice and stabilized rice bran products at its facility located in Wynn, Arkansas (“the GRR Business” and such transaction, “the GRR Transaction”) pursuant to an asset purchase agreement (the “Agreement”), as reported in the Company’s current report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on January 25, 2024.

 

The buyer acquired the Purchased Assets (as defined in “the Agreement”), which include, but are not limited to, all of the tangible and intangible assets, real properties leased and/or owned by the Company located in Wynne Arkansas, intellectual property, books and records and rights of every kind and nature and wherever located that exclusively relate to, or are exclusively used or held for the operation of and the use in connection with, the GRR Business other than excluded assets, including all accounts receivable.

 

Total consideration from the buyer to the Company was $2.15 million in cash.

 

The unaudited pro forma condensed consolidated financial statements have been developed by applying pro forma adjustments to the Company’s historical consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”) and give effect to the GRR Transaction. The unaudited pro forma condensed consolidated statements of operations for the nine months ended September 30, 2023, and for the year ended December 31, 2022, assume that the Transaction occurred as of January 1, 2022.

 

The unaudited pro forma condensed consolidated statements of operations for the year ended December 31, 2022 also assume that the Company’s June 23, 2023 sale of certain assets exclusively related to the Company’s production of stabilized rice bran and processing of stabilized rice bran into stabilized rice bran derivatives at its facilities located in West Sacramento, California, Mermentau, Louisiana, Lake Charles, Louisiana and Dillon, Montana (the “SRB Transaction”) reported in the Company’s current report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on June 28, 2023 occurred as of January 1, 2022.

 

The unaudited pro forma condensed consolidated balance sheet as of September 30, 2023, assumes that the GRR Transaction [and the SRB Transaction] occurred on that date. The unaudited pro forma condensed consolidated financial statements are presented based on currently available information and are intended for informational purposes only.

 

These unaudited pro forma condensed consolidated financial statements are not necessarily indicative of what the Company’s results of operations or financial condition would have been had the GRR Transaction and the SRB Transaction been completed on the dates assumed. In addition, they are not necessarily indicative of the Company’s future results of operations or financial condition. Beginning in the first quarter of 2024, the historical financial results of the GRR Business for periods prior to the Transaction will be reflected in the Company’s consolidated financial statements as discontinued operations.

 

 

 

The unaudited pro forma condensed consolidated financial statements have been derived from historical financial statements prepared in accordance with US GAAP and are presented based on assumptions, adjustments, and currently available information described in the accompanying notes. They are intended for informational purposes only and are not intended to represent the Company’s financial position or results of operations had the disposition occurred on the dates indicated, or to project the Company’s financial performance for any future period. Pro forma adjustments have been made for events that are directly attributable to the disposition and factually supportable.

 

Article 11 of Regulation S-X requires that pro forma financial information include the following pro forma adjustments to the historical financial statements of the registrant as follows:

 

● Transaction Accounting Adjustments – Adjustments that reflect only the application of required accounting to the acquisition, disposition, or other transaction.

 

● Autonomous Entity Adjustments – Adjustments that are necessary to reflect the operations and financial position of the registrant as an autonomous entity when the registrant was previously part of another entity.

 

In addition, Regulation S-X permits registrants to reflect adjustments that depict synergies and dis-synergies of the acquisitions and dispositions for which pro forma effect is being given in our disclosures as management adjustments.

 

The transaction accounting adjustments to reflect the GRR Business in the unaudited pro forma condensed consolidated financial statements include:

 

● The sale of the assets and liabilities of the GRR Business pursuant to the Agreement

 

● Estimated impact of the cash proceeds received in connection with the transaction, net of transaction costs and income taxes

 

There are no autonomous entity adjustments included in the pro forma financial information. Additionally, the unaudited pro forma condensed consolidated financial statements do not include management adjustments to reflect any potential synergies that may be achievable or dis-synergy costs that may occur in connection with the Transaction.

 

The unaudited pro forma condensed consolidated financial statements have been prepared in accordance with Article 11 of Regulation S-X and should be read in conjunction with (i) the accompanying notes to the unaudited pro forma condensed consolidated financial statements, (ii) the audited consolidated financial statements and accompanying notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s Form 10-K as of December 31, 2022, and for the year then ended, filed with the SEC on March 16, 2023, and (iii) the unaudited condensed consolidated financial statements and accompanying notes and “Management’s Discussion and Analysis of Financial Conditions and Results of Operations” included in the Company’s Form 10-Q as of September 30, 2023, and for the three months then ended, filed with the SEC on December 20, 2023.

 

 

 

RiceBran Technologies

Pro Forma Condensed Consolidated Statement of Operations

Unaudited Nine Months ended September 30, 2023

(in thousands, except share and per share amounts)

 

 

   

As Reported

   

Pro Forma Adjustments

 

Notes

 

Pro Forma

 
                           

Revenues

  $ 16,970     $ (11,535 )

(f)

  $ 5,435  

Cost of goods sold

    17,484       (12,675 )

(f)

    4,809  

Gross loss

    (514 )     1,140         626  

Selling, general and administrative expenses

    4,352                 4,352  

Loss from continuing operations before other income (expense)

    (4,866 )     1,140         (3,726 )

Interest income

    26                 26  

Interest expense

    (476 )     314  

(g)

    (162 )

Change in fair value of derivative warrant liability

    14                 14  

Other expense

    (3 )     35  

(h)

    32  

Other income

    178                 178  

Loss from continuing operations before income taxes

    (5,121 )     1,419         (3,702 )

Income tax expense

    (11 )        

(i)

    (11 )

Loss from continuing operations

    (5,132 )     1,419         (3,713 )

Loss from discontinued operations

    (9,009 )               (9,009 )

Net loss

  $ (14,141 )     1,419       $ (12,722 )

Basic and diluted loss per common share:

                         

Continuing operations

  $ (0.77 )             $ (0.55 )

Discontinued operations

    (1.34 )               (1.34 )
    $ (2.11 )             $ (1.90 )

Weighted average number of shares outstanding:

                         

Basic

    6,699,963                 6,699,963  

Diluted

    6,699,963                 6,699,963  

 

 

 

RiceBran Technologies

Pro Forma Condensed Consolidated Statement of Operations

Unaudited Year ended December 31, 2022

(in thousands, except share and per share amounts)

 

   

As Reported

   

SRB Pro Forma Adjustments

 

Notes

 

SRB Pro Forma

   

GRR Pro Forma Adjustments

 

Notes

 

GRR Pro Forma

 
                                             

Revenues

  $ 41,617     $ (14,970 )

(a)

  $ 26,647     $ (17,478 )

(f)

  $ 9,169  

Cost of goods sold

    42,376       (14,966 )

(a)

    27,410       (18,991 )

(f)

    8,419  

Gross loss

    (759 )     (4 )       (763 )     1,513         750  

Selling, general and administrative expenses

    6,690       (1,393 )

(b)

    5,297                 5,297  

Gain on involuntary conversion of property and equipment

    (147 )     147  

(b)

    -                 -  

Operating loss

    (7,302 )     1,242         (6,060 )     1,513         (4,547 )

Other income (expense):

                                           

Interest expense

    (572 )     3  

(c)

                         
              53  

(d)

    (516 )     341  

(g)

    (175 )

Interest income

    22       -         22                 22  

Change in fair value of derivative warrant liability

    189       -         189                 189  

Other income

    7       -         7                 7  

Other expense

    (183 )     -         (183 )     (27 )

(h)

    (210 )

Loss before income taxes

    (7,839 )     1,298         (6,541 )     1,827         (4,714 )

Income tax expense

    (19 )     -  

(e)

    (19 )        

(i)

    (19 )

Net loss

  $ (7,858 )   $ 1,298       $ (6,560 )   $ 1,827       $ (4,733 )
                                             

Loss per common share:

                                           

Basic

  $ (1.42 )             $ (1.19 )             $ (0.86 )

Diluted

  $ (1.42 )             $ (1.19 )             $ (0.86 )
                                             

Weighted average number of shares outstanding:

                                           

Basic

    5,514,671                 5,514,671                 5,514,671  

Diluted

    5,514,671                 5,514,671                 5,514,671  

 

 

 

RiceBran Technologies

Pro Forma Condensed Consolidated Balance Sheet

Unaudited Year ended September 30, 2023

(in thousands, except share amounts)

 

   

As Reported

   

Pro Forma Adjustments

 

Notes

 

Pro Forma

 

ASSETS

                         

Current assets:

                         

Cash and cash equivalents

  $ 466     $ 1,672  

(j)

  $ 2,138  

Accounts receivable, net of allowance for credit losses of $49 and $27

    2,620                 2,620  

Inventories

    514                 514  

Other current assets

    515                 515  

Current assets held for sale

    -                 -  

Total current assets

    4,115       1,672         5,787  

Property and equipment, net

    5,937       (3,825 )

(k)

    2,112  

Operating lease right-of-use assets

    -                 -  

Intangible assets

    295                 295  

Long-term assets held for sale

    -                 -  

Total assets

  $ 10,347     $ (2,153 )     $ 8,194  

LIABILITIES AND SHAREHOLDERS' EQUITY

                         

Current liabilities:

                         

Accounts payable

  $ 1,414               $ 1,414  

Commodities payable

    2,538                 2,538  

Accrued salary, wages and benefits

    438                 438  

Accrued legal

    1,545                 1,545  

Accrued expenses

    590       (92 )

(j)

    498  

Operating lease liabilities, current portion

    -                 -  

Due under bank line of credit

    -                 -  

Due under factoring agreement

    1,910       (250 )

(l)

    1,660  

Due under insurance premium finance agreements

    195                 195  

Finance lease liabilities, current portion

    136                 136  

Long-term debt, current portion

    1,273                 1,273  

Current liabilities held for sale

    -                 -  

Total current liabilities

    10,039       (342 )       9,697  

Finance lease liabilities, less current portion

    434                 434  

Long-term debt, less current portion

    603                 603  

Derivative warrant liability

    55                 55  

Long-term liabilities held for sale

    -                 -  

Total liabilities

    11,131       (342 )       10,789  

Commitments and contingencies

                         

Shareholders' equity (deficit):

                         

Preferred stock, 20,000,000 shares authorized: Series G, convertible, 3,000 shares authorized, stated value $ 150 , 150 shares, issued and outstanding

    75                 75  

Common stock, no par value, 15,000,000 shares authorized, 6,608,376 shares and 6,309,509 shares, issued and outstanding

    328,999                 328,999  

Accumulated deficit

    (329,858 )     (1,811 )       (331,669 )

Total shareholders' equity (deficit)

    (784 )     (1,811 )       (2,595 )

Total liabilities and shareholders' equity

  $ 10,347     $ (2,153 )     $ 8,194  

 

 

 

RiceBran Technologies

Notes to Unaudited Pro Forma Condensed Consolidated Financial Statements

 

The unaudited pro forma condensed consolidated financial statements give effect to the SRB Transaction to be accounted for as a discounted operation.

The unaudited pro forma condensed consolidated statements of operations for the three months ended March 31, 2023, and for the year ended December 31, 2022, are presented as if the SRB Transaction occurred as of January 1, 2022.

The unaudited pro forma condensed consolidated balance sheet as of March 31, 2023, is presented as if the sale occurred on that date.

 

(a)

This adjustment reflects the elimination of the profit and loss of the SRB Business for the period presented.

(b)

This adjustment reflects the elimination of operating expenses of the SRB Business, excluding the anticipated effects of other costs that may be reduced or eliminated as a result of having completed the sale.

(c)

This adjustment reflects the elimination of interest expense related to the debt assumed by the buyer.

(d)

This adjustment reflects the elimination of interest expense related to the debt related to the repayment of a portion of the amount outstanding on the Company's mortgage promissory note (not exclusively related to the SRB Business) from proceeds of the SRB Transaction. The note was secured by the Company's real property in Arkansas.

(e)

No income tax adjustment has been made to the unaudited pro forma condensed consolidated statement of operations based upon the Company's existing U.S. valuation allowance position.

 

The unaudited pro forma condensed consolidated financial statements give effect to the GRR Transaction to be accounted for as a discontinued operation.

The unaudited pro forma condensed consolidated statements of operations for the nine months ended September 30, 2023, and for the year ended December 31, 2022, are presented as if the GRR Transaction occurred as of January 1, 2022.

The unaudited pro forma condensed consolidated balance sheet as of September 30, 2023, is presented as if the sale occurred on that date.

 

(f)

This adjustment reflects the elimination of the profit and loss of the GRR Business for the period presented.

(g)

This adjustment reflects the elimination of interest expense related to the debt related to the factoring of the GRR Business receivables.

(h)

This adjustment reflects the $86k factoring termination fee less elimination of other expense directly related to the GRR Business receivables.

(i)

No income tax adjustment has been made to the unaudited pro forma condensed consolidated statement of operations based upon the Company's existing U.S. valuation allowance position.

(j)

This adjustment reflects the $2,150k cash consideration received at closing of the GRR Transaction less $50k of legal expenses paid related to it, the amounts paid to the factoring lender (see h and l) and $92k of advisory fees paid and recorded against the minimum advsiory fee accrued as part of the prior SRB Transaction.

(k)

This adjustment reflects the elimination of the net book value of the GRR Business assets sold.

(l)

This adjustment reflects the repayment of a portion of the factoring advance as required by the lender to consent to the GRR Transaction.